JP2020520372A5 - - Google Patents

Download PDF

Info

Publication number
JP2020520372A5
JP2020520372A5 JP2019563617A JP2019563617A JP2020520372A5 JP 2020520372 A5 JP2020520372 A5 JP 2020520372A5 JP 2019563617 A JP2019563617 A JP 2019563617A JP 2019563617 A JP2019563617 A JP 2019563617A JP 2020520372 A5 JP2020520372 A5 JP 2020520372A5
Authority
JP
Japan
Prior art keywords
gly
leu
ala
gln
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019563617A
Other languages
English (en)
Japanese (ja)
Other versions
JP7680824B2 (ja
JP2020520372A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2018/005673 external-priority patent/WO2018225961A1/ko
Publication of JP2020520372A publication Critical patent/JP2020520372A/ja
Publication of JP2020520372A5 publication Critical patent/JP2020520372A5/ja
Priority to JP2023061251A priority Critical patent/JP7775250B2/ja
Application granted granted Critical
Publication of JP7680824B2 publication Critical patent/JP7680824B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019563617A 2017-05-17 2018-05-17 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物 Active JP7680824B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023061251A JP7775250B2 (ja) 2017-05-17 2023-04-05 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2017-0061250 2017-05-17
KR20170061250 2017-05-17
PCT/KR2018/005673 WO2018225961A1 (ko) 2017-05-17 2018-05-17 신규한 펩타이드 및 이를 유효성분으로 포함하는 안구질환 치료용 약학 조성물

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023061251A Division JP7775250B2 (ja) 2017-05-17 2023-04-05 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物

Publications (3)

Publication Number Publication Date
JP2020520372A JP2020520372A (ja) 2020-07-09
JP2020520372A5 true JP2020520372A5 (enExample) 2021-07-26
JP7680824B2 JP7680824B2 (ja) 2025-05-21

Family

ID=64566301

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019563617A Active JP7680824B2 (ja) 2017-05-17 2018-05-17 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物
JP2023061251A Active JP7775250B2 (ja) 2017-05-17 2023-04-05 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023061251A Active JP7775250B2 (ja) 2017-05-17 2023-04-05 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物

Country Status (13)

Country Link
US (1) US12037415B2 (enExample)
EP (1) EP3643723B1 (enExample)
JP (2) JP7680824B2 (enExample)
KR (2) KR102287226B1 (enExample)
CN (1) CN110945012A (enExample)
AU (1) AU2018281617B2 (enExample)
BR (1) BR112019024040A2 (enExample)
CA (1) CA3063842A1 (enExample)
ES (1) ES2982308T3 (enExample)
MX (1) MX2019013799A (enExample)
RU (1) RU2766160C2 (enExample)
SG (1) SG11201912110YA (enExample)
WO (1) WO2018225961A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2766160C2 (ru) * 2017-05-17 2022-02-08 Юю Фарма, Инк. Новый пептид и фармацевтический состав для лечения глазного заболевания, содержащий пептид в качестве активного фармацевтического ингредиента
TWI865470B (zh) * 2018-11-14 2024-12-11 南韓商柳柳製藥股份有限公司 治療眼睛疾病之肽及醫藥組合物
US11613558B2 (en) 2018-11-14 2023-03-28 Yuyu Pharma, Inc. Peptides and pharmaceutical compositions for treating eye diseases
BR112021023477A2 (pt) * 2019-05-21 2022-02-15 Eyebio Korea Novo composto peptídico, composição farmacêutica para prevenir ou tratar inflamação, composição de alimento para prevenir ou amenizar a inflamação e composição de cosmético tendo um efeito anti inflamatório
KR20210104460A (ko) * 2020-02-17 2021-08-25 주식회사 아이바이오코리아 고체상 합성법을 이용한 펩타이드의 제조 방법
CA3170606A1 (en) * 2020-03-05 2021-09-30 Wonsang YU Treatment of inflammatory diseases with peptides and pharmaceutical compositions
KR102593936B1 (ko) * 2021-12-13 2023-10-27 주식회사 아이바이오코리아 신규한 펩타이드를 포함하는 황반변성의 치료용 조성물
EP4450079A4 (en) * 2021-12-13 2025-12-10 Eyebiokorea Inc COMPOSITION FOR THE TREATMENT OF MACULAR DEGENERATION COMPRISING A NEW PEPTIDE
KR102587729B1 (ko) * 2023-02-27 2023-10-12 주식회사 아이바이오코리아 펩타이드를 포함하는 당뇨망막병증의 치료용 조성물
KR102673860B1 (ko) * 2023-08-10 2024-06-12 (주)케어젠 안구 건조증의 개선 활성을 갖는 펩타이드 및 이의 용도

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
WO2007117444A2 (en) * 2006-03-31 2007-10-18 Yinghe Hu Protein detection by aptamers
US10611818B2 (en) 2007-09-27 2020-04-07 Agilent Technologies, Inc. MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
US20090131303A1 (en) 2007-11-16 2009-05-21 Bor-Shyue Hong Methods and compositions for treating dry eye
JP4490498B2 (ja) * 2008-09-30 2010-06-23 新田ゼラチン株式会社 疾病抑制剤
MY180581A (en) 2011-05-27 2020-12-02 Allergan Inc A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
JP2015500213A (ja) * 2011-11-30 2015-01-05 ザイジェン インフラメーション リミテッド 眼乾燥症候群を処置するためのjnkシグナル伝達経路の細胞透過性ペプチド阻害剤の使用
KR101438744B1 (ko) * 2012-08-02 2014-09-15 전남대학교산학협력단 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물
KR101555296B1 (ko) 2013-12-10 2015-09-23 인제대학교 산학협력단 연골세포 유래 세포외 기질을 유효성분으로 함유하는 건성안 예방 또는 치료용 약학조성물
KR101948156B1 (ko) 2013-12-10 2019-02-14 인제대학교 산학협력단 알칼리 화상을 이용한 각막 혼탁증 동물모델 및 각막 혼탁증 예방 또는 치료용 약학조성물
KR101721059B1 (ko) * 2014-12-26 2017-03-30 주식회사 아이바이오코리아 안구 표면 질환 예방 또는 치료용 약학조성물
KR101690539B1 (ko) 2015-07-30 2016-12-29 주식회사 아이바이오코리아 건성안 예방 또는 치료용 약학조성물
TWI675851B (zh) 2015-12-14 2019-11-01 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院 短合成胜肽及其用途
KR101798183B1 (ko) * 2016-04-08 2017-11-15 주식회사 아이바이오코리아 건성안 예방 또는 치료용 약학조성물
EP3539559B1 (en) 2016-04-08 2020-08-26 Eyebio Korea Collagen type ii alpha-1-based peptide for use in the treatment of macular degeneration
KR101795653B1 (ko) 2016-05-19 2017-11-09 인제대학교 산학협력단 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물
KR20180074928A (ko) 2016-12-26 2018-07-04 주식회사 아이바이오코리아 건성안 예방 또는 치료용 동물 의약품 조성물
RU2766160C2 (ru) 2017-05-17 2022-02-08 Юю Фарма, Инк. Новый пептид и фармацевтический состав для лечения глазного заболевания, содержащий пептид в качестве активного фармацевтического ингредиента
TWI865470B (zh) 2018-11-14 2024-12-11 南韓商柳柳製藥股份有限公司 治療眼睛疾病之肽及醫藥組合物
US11613558B2 (en) 2018-11-14 2023-03-28 Yuyu Pharma, Inc. Peptides and pharmaceutical compositions for treating eye diseases
CA3170606A1 (en) 2020-03-05 2021-09-30 Wonsang YU Treatment of inflammatory diseases with peptides and pharmaceutical compositions

Similar Documents

Publication Publication Date Title
JP2020520372A5 (enExample)
RU2019141646A (ru) Новый пептид и фармацевтический состав для лечения глазного заболевания, содержащий пептид в качестве активного фармацевтического ингредиента
KR102666477B1 (ko) 글루타민 유사체의 프로드럭
AU2018217860B2 (en) 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
JP2022507404A5 (enExample)
CN105683211B (zh) 新型多肽
CA2554809C (en) Novel n-alkyl thiourea- and thioamide-substituted imidazolyl inhibitors of glutaminyl cyclase
CN102712628B (zh) 丙型肝炎病毒抑制剂
AU2010208071B2 (en) Cyclosporin analogues for preventing or treating hepatitis C infection
TWI542589B (zh) C型肝炎病毒抑制劑
JP2021105013A (ja) タンパク質調節因子として有用な複素環式アミド
JP2025108559A (ja) ウイルス感染症の治療のための組成物及び方法
TW201927771A (zh) 可作為蛋白質調節劑之雜環醯胺及其使用方法
TW200826938A (en) Hepatitis C virus inhibitors
CN113194983A (zh) 用于治疗病毒感染的组合物及方法
CN105813640A (zh) 作为免疫调节剂的环肽类化合物
AU2016258837B2 (en) Peptide compositions and methods of use
KR20120110091A (ko) Hcv 프로테아제 저해제
CA2394350A1 (en) Lipopeptides as antibacterial agents
TW201643178A (zh) 在MeBmt側鏈上經雜環修飾之環孢靈素
AU2013249344A1 (en) Compositions and methods for inhibiting viral polymerase
CN114401731A (zh) 用于治疗人类免疫缺陷病毒的组合物及方法
CA2925291A1 (en) Substituted phenylalanine derivatives
CA3233410A1 (en) Benzimidazoles as modulators of il-17
WO2024010810A2 (en) Fc conjugates including an inhibitor of cd73 and uses thereof